Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.21.2
Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock
APIC
Accumulated Deficit
Accumulated Other Comprehensive Gain (Loss)
Non-Controlling Interest
Total
Beginning Balance at Dec. 31, 2019 $ 965 $ 118,179,635 $ (104,597,748) $ (11,250) $ (413,752) $ 13,157,850
January 2020 investment offering, net of underwriters discounts 571 4,105,577       4,106,148
Issuance of common stock under ATM, net of issuance costs 2,612 116,294,150       116,296,762
Issuance of common stock from vesting of restricted stock awards 47 (47)        
Stock issuance costs   (3,076,915)       (3,076,915)
Stock based compensation   6,050,094       6,050,094
Exercise of warrants 227 3,442,095       3,442,322
Exchange of warrants 64 773,266       773,330
Other comprehensive income (loss)       (24,660)   (24,660)
Net loss     (19,598,145)   (228,526) (19,826,671)
Ending Balance at Sep. 30, 2020 4,486 245,767,855 (124,195,893) (35,910) (642,278) 120,898,260
Beginning Balance at Jun. 30, 2020 3,144 163,026,420 (115,344,284) 28,044 (577,454) 47,135,870
Issuance of common stock under ATM, net of issuance costs 1,330 79,296,779       79,298,109
Stock issuance costs   (1,984,155)       (1,984,155)
Stock based compensation   4,728,894       4,728,894
Exercise of warrants 12 699,917       699,929
Other comprehensive income (loss)       (63,954)   (63,954)
Net loss     (8,851,609)   (64,824) (8,916,433)
Ending Balance at Sep. 30, 2020 4,486 245,767,855 (124,195,893) (35,910) (642,278) 120,898,260
Beginning Balance at Dec. 31, 2020 4,519 247,048,349 (130,647,485) (166,056) (745,404) 115,493,923
Issuance of common stock under ATM, net of issuance costs 420 26,303,862       26,304,282
Issuance of common stock from vesting of restricted stock awards 83 (83)        
Stock issuance costs   (658,184)       (658,184)
Stock based compensation   4,376,588       4,376,588
Issuance of restricted stock 3 (3)        
Exercise of options 6 27,255       27,261
Cancellation and payout of fractional shares (3) 3        
Other comprehensive income (loss)       113,511   113,511
Net loss     (21,508,095)   (283,846) (21,791,941)
Ending Balance at Sep. 30, 2021 5,028 277,097,787 (152,155,580) (52,545) (1,029,250) 123,865,440
Beginning Balance at Jun. 30, 2021 5,027 276,225,048 (144,722,860) (121,127) (913,745) 130,472,343
Issuance of common stock from vesting of restricted stock awards 1 (1)        
Stock based compensation   872,740       872,740
Other comprehensive income (loss)       68,582   68,582
Net loss     (7,432,720)   (115,505) (7,548,225)
Ending Balance at Sep. 30, 2021 $ 5,028 $ 277,097,787 $ (152,155,580) $ (52,545) $ (1,029,250) $ 123,865,440